Latest filing published 17 Feb 2026 for Tenaya Therapeutics, Inc., €332.
Filing timeline
BuySaleInsider track record
Tomohiro Higa: trading record in brief
Tomohiro Higa is a declared insider of Tenaya Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 10 March 2025 and the latest from 17 February 2026.
The open-market record consists of 11 sales worth €8,403, with no purchase. Besides market trades, the filings include 1 share grant. So far in 2026, the count stands at no purchases and 3 sales.
Most recently, on 17 February 2026, the filings show an open-market sale worth €454 in Tenaya Therapeutics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tomohiro Higa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 611 shares@ US$0.64349.4% of flowCommon StockSEC:0001193125-26-055445:0
- 29,250 shares0Common StockSEC:0001193125-26-039768:0
- 1,367 shares@ US$1.3344.6% of flowCommon StockSEC:0001193125-25-284999:0
- 523 shares@ US$1.25316.0% of flowCommon StockSEC:0000950170-25-109915:0
- 1,390 shares@ US$0.442715.7% of flowCommon StockSEC:0000950170-25-073825:0
- 1,017 shares@ US$0.538414.4% of flowCommon StockSEC:0000950170-25-036774:0
6 of 6 declarations
